Online Program Home
My Program

Abstract Details

Activity Number: 481 - Modeling, Analysis, and Assessment
Type: Contributed
Date/Time: Wednesday, August 1, 2018 : 8:30 AM to 10:20 AM
Sponsor: Quality and Productivity Section
Abstract #328447 Presentation
Title: A Reflection of the Statistical Assessment for Analytical Similarity and Beyond ----Are We Addressing the Right Question?
Author(s): Aili Cheng*
Companies: Pfizer
Keywords: biosimilars; analytical similarity; equivalence test
Abstract:

With more recent biosimilar approvals in the pharmaceutical industry, the regulation on the assessment of the analytical similarity is heading towards maturity, especially in the US. The FDA draft guidance on analytical similarity, although still at the draft stage, does set up a common statistical pathway for the industry to follow. However, there are still quite a few challenges left in implementation of the guidance. This presentation will talk about these challenges, possible solutions, and the potential impact of these methodologies on other settings where similarity might be assessed.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program